17-31219119-G-C
Variant summary
Our verdict is Pathogenic. The variant received 26 ACMG points: 26P and 0B. PS1_Very_StrongPM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000487476.5(NF1):c.1642G>C(p.Val548Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V548A) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000487476.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 26 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000487476.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NF1 | NM_001042492.3 | MANE Select | c.1641+1G>C | splice_donor intron | N/A | NP_001035957.1 | |||
| NF1 | NM_000267.4 | c.1641+1G>C | splice_donor intron | N/A | NP_000258.1 | ||||
| NF1 | NM_001128147.3 | c.1641+1G>C | splice_donor intron | N/A | NP_001121619.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NF1 | ENST00000487476.5 | TSL:1 | c.1642G>C | p.Val548Leu | missense | Exon 14 of 14 | ENSP00000491589.1 | ||
| NF1 | ENST00000358273.9 | TSL:1 MANE Select | c.1641+1G>C | splice_donor intron | N/A | ENSP00000351015.4 | |||
| NF1 | ENST00000356175.7 | TSL:1 | c.1641+1G>C | splice_donor intron | N/A | ENSP00000348498.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:2
The variant is not observed in the gnomAD v2.1.1 dataset. Canonical splice site is predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported to be associated with NF1 -related disorder (ClinVar ID: VCV000996419). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at